US OptionsDetailed Quotes
AMED240719C95000
- 3.00
- 0.000.00%
15min DelayClose Jul 8 16:00 ET
0.00High0.00Low
3.00Open3.00Pre Close0 Volume41 Open Interest95.00Strike Price0.00Turnover0.00%IV0.81%PremiumJul 19, 2024Expiry Date2.21Intrinsic Value100Multiplier11DDays to Expiry0.79Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma48.61Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Amedisys Stock Discussion
Sign in to post a comment
$Amedisys(AMED.US$ divergency with good fundamental Also gap so it looks good and risk to rewards is acceptable
1
$Inhibikase Therapeutics(IKT.US$
learn from
$Amedisys(AMED.US$
$AMC Entertainment(AMC.US$
$Fulcrum Therapeutics(FULC.US$
JonesTrading analyst Soumit Roy initiates coverage on Inhibikase Therapeutics (NASDAQ:IKT) with a Buy rating and announces Price Target of $12.
$PharmaCyte Biotech(PMCB.US$
learn from
$Amedisys(AMED.US$
$AMC Entertainment(AMC.US$
$Fulcrum Therapeutics(FULC.US$
JonesTrading analyst Soumit Roy initiates coverage on Inhibikase Therapeutics (NASDAQ:IKT) with a Buy rating and announces Price Target of $12.
$PharmaCyte Biotech(PMCB.US$
2
No comment yet
Kofi : Do u see it going above 100 ?